130 related articles for article (PubMed ID: 33608980)
41. CLEC10A is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in lung adenocarcinoma.
He M; Han Y; Cai C; Liu P; Chen Y; Shen H; Xu X; Zeng S
J Cell Mol Med; 2021 Apr; 25(7):3391-3399. PubMed ID: 33655701
[TBL] [Abstract][Full Text] [Related]
42. Knowledge-based classification of fine-grained immune cell types in single-cell RNA-Seq data.
Liu X; Gosline SJC; Pflieger LT; Wallet P; Iyer A; Guinney J; Bild AH; Chang JT
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33681983
[TBL] [Abstract][Full Text] [Related]
43. SUV39H1 deficiency suppresses clear cell renal cell carcinoma growth by inducing ferroptosis.
Wang J; Yin X; He W; Xue W; Zhang J; Huang Y
Acta Pharm Sin B; 2021 Feb; 11(2):406-419. PubMed ID: 33643820
[TBL] [Abstract][Full Text] [Related]
44. Prognostic value of tumour microenvironment-related genes by TCGA database in rectal cancer.
Li C; Liu T; Liu Y; Zhang J; Zuo D
J Cell Mol Med; 2021 Jun; 25(12):5811-5822. PubMed ID: 33949771
[TBL] [Abstract][Full Text] [Related]
45. Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Lung Adenocarcinoma.
Luo L; Zheng Y; Lin Z; Li X; Li X; Li M; Cui L; Luo H
J Immunol Res; 2021; 2021():6647122. PubMed ID: 33928169
[TBL] [Abstract][Full Text] [Related]
46. Expressional and Prognostic Value of S100A16 in Pancreatic Cancer
Tu G; Gao W; Li Y; Dian Y; Xue B; Niu L; Yu X; Zhu H
Front Cell Dev Biol; 2021; 9():645641. PubMed ID: 33912559
[TBL] [Abstract][Full Text] [Related]
47. The Effect of Cognitive Intervention on Cognitive Function in Older Adults With Alzheimer's Disease: A Systematic Review and Meta-Analysis.
Wang YY; Yang L; Zhang J; Zeng XT; Wang Y; Jin YH
Neuropsychol Rev; 2022 Jun; 32(2):247-273. PubMed ID: 33893905
[TBL] [Abstract][Full Text] [Related]
48.
Qu S; Liu J; Wang H
Front Immunol; 2021; 12():648416. PubMed ID: 33889156
[TBL] [Abstract][Full Text] [Related]
49. Overexpressed pseudogene MT1L associated with tumor immune infiltrates and indicates a worse prognosis in BLCA.
Ding Y; Liu N; Chen M; Xu Y; Fang S; Xiang W; Hua X; Chen G; Zhong Y; Yu H
World J Surg Oncol; 2021 Apr; 19(1):133. PubMed ID: 33888142
[TBL] [Abstract][Full Text] [Related]
50. Integrative Transcriptomic, Proteomic and Functional Analysis Reveals ATP1B3 as a Diagnostic and Potential Therapeutic Target in Hepatocellular Carcinoma.
Lu S; Cai S; Peng X; Cheng R; Zhang Y
Front Immunol; 2021; 12():636614. PubMed ID: 33868261
[TBL] [Abstract][Full Text] [Related]
51. Bioinformatic analysis identifying FGF1 gene as a new prognostic indicator in clear cell Renal Cell Carcinoma.
Zhang X; Wang Z; Zeng Z; Shen N; Wang B; Zhang Y; Shen H; Lu W; Wei R; Ma W; Wang C
Cancer Cell Int; 2021 Apr; 21(1):222. PubMed ID: 33865387
[TBL] [Abstract][Full Text] [Related]
52. Integrated Profiling Identifies CCNA2 as a Potential Biomarker of Immunotherapy in Breast Cancer.
Wang Y; Zhong Q; Li Z; Lin Z; Chen H; Wang P
Onco Targets Ther; 2021; 14():2433-2448. PubMed ID: 33859479
[TBL] [Abstract][Full Text] [Related]
53. Centromere Protein F (
Huang Y; Chen X; Wang L; Wang T; Tang X; Su X
J Cancer; 2021; 12(10):2933-2951. PubMed ID: 33854594
[TBL] [Abstract][Full Text] [Related]
54. Downregulated ZNF132 predicts unfavorable outcomes in breast Cancer via Hypermethylation modification.
Liu Z; Liu J; Liu R; Xue M; Zhang W; Zhao X; Zhu J; Xia P
BMC Cancer; 2021 Apr; 21(1):367. PubMed ID: 33827486
[TBL] [Abstract][Full Text] [Related]
55. CXCL12 and CD3E as Indicators for Tumor Microenvironment Modulation in Bladder Cancer and Their Correlations With Immune Infiltration and Molecular Subtypes.
Liu Y; Wu Y; Zhang P; Xu C; Liu Z; He C; Liu Y; Kang Z
Front Oncol; 2021; 11():636870. PubMed ID: 33747959
[TBL] [Abstract][Full Text] [Related]
56. Identification of Stemness Characteristics Associated With the Immune Microenvironment and Prognosis in Gastric Cancer.
Mao D; Zhou Z; Song S; Li D; He Y; Wei Z; Zhang C
Front Oncol; 2021; 11():626961. PubMed ID: 33747944
[TBL] [Abstract][Full Text] [Related]
57. KPNA2 interaction with CBX8 contributes to the development and progression of bladder cancer by mediating the PRDM1/c-FOS pathway.
Zeng F; Luo L; Li D; Guo J; Guo M
J Transl Med; 2021 Mar; 19(1):112. PubMed ID: 33731128
[TBL] [Abstract][Full Text] [Related]
58. Ferroptosis-related gene CHAC1 is a valid indicator for the poor prognosis of kidney renal clear cell carcinoma.
Li D; Liu S; Xu J; Chen L; Xu C; Chen F; Xu Z; Zhang Y; Xia S; Shao Y; Wang Y
J Cell Mol Med; 2021 Apr; 25(7):3610-3621. PubMed ID: 33728749
[TBL] [Abstract][Full Text] [Related]
59. Experience in identifying the variant adrenal venous anatomy during modified retroperitoneoscopic adrenalectomy.
Hu D; Zhu D; Zhang Y; Wang X
J Minim Access Surg; 2021; 17(2):175-179. PubMed ID: 33723181
[TBL] [Abstract][Full Text] [Related]
60. Identification of a prognostic signature based on immune-related genes in bladder cancer.
Lv Z; Pang C; Wang J; Xia H; Liu J; Yan Q; Liu S; Liu M; Wang J
Genomics; 2021 May; 113(3):1203-1218. PubMed ID: 33711453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
